Dapagliflozin release date?

When was dapagliflozin first released (approved)?

Dapagliflozin (Farxiga/Forxiga) was first approved by the U.S. Food and Drug Administration (FDA) in 2014 for type 2 diabetes. [1]

What product names and markets are commonly associated with dapagliflozin?

In the U.S., dapagliflozin is marketed as Farxiga. In many other countries, you may see it sold as Forxiga. [1]

How do approvals for other uses affect the “release date” you may see online?

Online sources sometimes show different “release dates” depending on what the person means by release:
- initial approval for type 2 diabetes (2014 in the U.S.)
- later approvals for additional indications (new disease/endpoint label expansions after the first approval)

Because indication-specific approvals happen after the drug’s first launch, the date you see can vary by indication. [1]

Patents and exclusivity: where to check for indication-specific timelines

For patent and exclusivity tracking tied to specific brands and markets, DrugPatentWatch.com maintains a drug-specific profile for dapagliflozin. [2]

Sources:
[1] https://www.drugs.com/history/dapagliflozin.html
[2] https://www.drugpatentwatch.com/p/dapagliflozin